Tuesday, November 12, 2019

Oncoceutics Hopes to Develop the First Effective Drug for High-Grade Glioma by Blocking Dopamine from Feeding the Deadly Cancer’s Growth

High-grade glioma is a deadly brain cancer with no effective long-term treatments, typically leaving children and adults with less than two years to live following diagnosis. Oncoceutics Inc. is tackling this challenge with a new investigational drug, ONC201, which...

Salarius Believes Children Should Not Be Left Behind in the Fight Against Cancer

Many pharmaceutical and biotech companies shy away from pediatric drug development. While the genomic revolution has resulted in scores of new cancer treatments for adults, children suffering from cancer have been left behind. It takes a spirit of determined commitment to real...

DelMar Developing Drug to Cross the Blood Brain Barrier to Treat Deadly Glioblastoma Disease

Glioblastoma Multiforme (GBM) is the most common and most lethal form of brain cancer. GBM affects an estimated 12,000 new patients each year in the US alone. The median survival in newly diagnosed patients with the best available treatments is 20.5 months.

Paving the Way to a New Generation of CNS Drugs: Karuna CEO Steve Paul, Neuroscience’s Renaissance Physician, Psychiatrist, Neuroscientist and Executive

By Rich Soll, Senior Advisor, Strategic Initiatives, WuXi AppTec (@richsollwx) and WuXi AppTec Content Team There are few who have Steve Paul’s perspective, experience and track-record in the neurosciences. A former scientific director at the NIMH/NIH, Paul was...

Halozyme Utilizing Unique Tumor Microenvironment Pathway to Fight Pancreatic Cancer

In WuXi AppTec’s latest series on novel drug development for pancreatic cancer, most of the companies featured have concentrated on ways to directly stimulate the patient’s own immune system to fight this stubborn disease. Halozyme, a clinical stage oncology company based in...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Dr. Ge Li Awarded “CEO of the Year” at CPhI Worldwide...

November 11, 2019: WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and...